BURKITT LYMPHOMA
Clinical trials for BURKITT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BURKITT LYMPHOMA trials appear
Sign up with your email to follow new studies for BURKITT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Punch T-Cells take aim at stubborn blood cancers
Disease control Not yet recruitingThis early study is testing a new type of cell therapy for patients whose B-cell lymphoma has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to attack two specific targets on the cancer cells (CD19 and CD…
Matched conditions: BURKITT LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Experimental drug targets tough blood cancers in early safety trial
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LY4152199 in people with B-cell lymphomas that have returned or didn't respond to previous treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping control the cancer. The study will enro…
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC